J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1016/S1470-2045(12)70137-7
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.29210/pdf

C. Fitzmaurice, D. Dicker, A. Pain, H. Hamavid, and M. Moradi-lakeh, The Global Burden of Cancer 2013, JAMA Oncology, vol.1, issue.4, pp.505-532, 2015.
DOI : 10.1001/jamaoncol.2015.0735

F. Barlesi, J. Mazieres, J. Merlio, D. Debieuvre, J. Mosser et al., Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), The Lancet, vol.387, issue.10026, pp.1415-1441, 2016.
DOI : 10.1016/S0140-6736(16)00004-0

G. Masters, S. Temin, C. Azzoli, G. Giaccone, S. Baker et al., Systemic Therapy for Stage IV Non???Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.33, issue.30, pp.3488-515, 2015.
DOI : 10.1200/JCO.2015.62.1342

P. Créquit, L. Trinquart, A. Yavchitz, and P. Ravaud, Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer, BMC Medicine, vol.349, issue.3, p.8, 2016.
DOI : 10.1136/bmj.g5579

J. Ioannidis and F. Karassa, The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence, BMJ, vol.341, issue.sep13 1, p.4875, 2010.
DOI : 10.1136/bmj.c4875

N. Hawkins, D. Scott, B. Woods, and N. Thatcher, No Study Left Behind: A Network Meta-Analysis in Non???Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data, Value in Health, vol.12, issue.6, pp.996-1003, 2009.
DOI : 10.1111/j.1524-4733.2009.00541.x

S. Popat, A. Mellemgaard, K. Fahrbach, A. Martin, M. Rizzo et al., Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis, Future Oncology, vol.29, issue.10, pp.409-429, 2015.
DOI : 10.1093/jnci/djt072

A. Chaimani, D. Caldwell, T. Li, J. Higgins, and G. Salanti, Additional considerations are required when preparing a protocol for a systematic review with multiple interventions, Journal of Clinical Epidemiology, vol.83, pp.65-74, 2017.
DOI : 10.1016/j.jclinepi.2016.11.015

B. Hutton, G. Salanti, D. Caldwell, A. Chaimani, C. Schmid et al., The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations, Annals of Internal Medicine, vol.162, issue.11, pp.777-84, 2015.
DOI : 10.7326/M14-2385

P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan et al., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-221, 2000.
DOI : 10.1093/jnci/92.3.205

A. Chan, Out of sight but not out of mind: how to search for unpublished clinical trial evidence, BMJ, vol.344, issue.jan03 2, p.8013, 2012.
DOI : 10.1136/bmj.d8013

P. Guyot, A. Ades, M. Ouwens, and N. Welton, Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves, BMC Medical Research Methodology, vol.14, issue.3, p.9, 2012.
DOI : 10.1080/1478336032000046643

J. Higgins, D. Altman, P. Gøtzsche, P. Jüni, D. Moher et al., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, vol.343, issue.oct18 2, p.5928, 2011.
DOI : 10.1136/bmj.d5928

G. Salanti, Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool, Research Synthesis Methods, vol.10, issue.1, pp.80-97, 2012.
DOI : 10.1186/1471-2288-10-54

A. Cipriani, J. Higgins, J. Geddes, and G. Salanti, Conceptual and Technical Challenges in Network Meta-analysis, Annals of Internal Medicine, vol.159, issue.2, pp.130-137, 2013.
DOI : 10.7326/0003-4819-159-2-201307160-00008
URL : http://annals.org/data/Journals/AIM/927247/0000605-201307160-00008.pdf

D. Caldwell, A. Ades, and J. Higgins, Simultaneous comparison of multiple treatments: combining direct and indirect evidence, BMJ, vol.331, issue.7521, pp.897-900, 2005.
DOI : 10.1136/bmj.331.7521.897
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1255806/pdf

G. Salanti, A. Ades, and J. Ioannidis, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, Journal of Clinical Epidemiology, vol.64, issue.2, pp.163-71, 2011.
DOI : 10.1016/j.jclinepi.2010.03.016

H. Bucher, G. Guyatt, L. Griffith, and S. Walter, The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials, Journal of Clinical Epidemiology, vol.50, issue.6, pp.683-91, 1997.
DOI : 10.1016/S0895-4356(97)00049-8

J. Higgins, D. Jackson, J. Barrett, G. Lu, A. Ades et al., Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies, Research Synthesis Methods, vol.11, issue.2, pp.98-110, 2012.
DOI : 10.1002/jrsm.1045
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433772/pdf

A. Chaimani, J. Higgins, D. Mavridis, P. Spyridonos, and G. Salanti, Graphical Tools for Network Meta-Analysis in STATA, PLoS ONE, vol.30, issue.474, p.76654, 2013.
DOI : 10.1371/journal.pone.0076654.s002
URL : https://doi.org/10.1371/journal.pone.0076654

A. Chaimani and G. Salanti, Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions, Research Synthesis Methods, vol.16, issue.23, pp.161-76, 2012.
DOI : 10.1002/(SICI)1097-0258(19971215)16:23<2741::AID-SIM703>3.0.CO;2-0

G. Salanti, D. Giovane, C. Chaimani, A. Caldwell, D. Higgins et al., Evaluating the Quality of Evidence from a Network Meta-Analysis, PLoS ONE, vol.67, issue.6, p.99682, 2014.
DOI : 10.1371/journal.pone.0099682.s003

R. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2016.

W. Viechtbauer, metaphor: Meta-Analysis Package for R. The R project. https://www.r-project.org/. Accessed 13, 2017.

D. Lunn, A. Thomas, N. Best, and D. Spiegelhalter, WinBUGS -A Bayesian modelling framework: Concepts, structure, and extensibility, Statistics and Computing, vol.10, issue.4, pp.325-362, 2000.
DOI : 10.1023/A:1008929526011

I. White, Network meta-analysis, Stata J, vol.15, issue.4, pp.951-85, 2015.

A. Chaimani and G. Salanti, Visualizing assumptions and results in network metaanlaysis: the network graphs package, Stata J, vol.15, issue.4, pp.905-50, 2015.

N. Elia, E. Von-elm, A. Chatagner, D. Pöpping, and M. Tramèr, How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors, BMJ Open, vol.9, issue.(2), p.10442, 2016.
DOI : 10.1371/journal.pone.0085846

R. Turner, J. Davey, M. Clarke, S. Thompson, and J. Higgins, Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews, International Journal of Epidemiology, vol.41, issue.3, pp.818-845, 2012.
DOI : 10.1093/ije/dys041

J. Neal, S. Dahlberg, H. Wakelee, S. Aisner, M. Bowden et al., Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial, The Lancet Oncology, vol.17, issue.12, pp.1661-71, 2016.
DOI : 10.1016/S1470-2045(16)30561-7

H. Uno, B. Claggett, and L. Tian, Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis, Journal of Clinical Oncology, vol.32, issue.22, pp.2380-2385, 2014.
DOI : 10.1200/JCO.2014.55.2208

L. Trinquart, J. Jacot, S. Conner, and R. Porcher, Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials, Journal of Clinical Oncology, vol.34, issue.15, pp.1813-1822, 2016.
DOI : 10.1200/JCO.2015.64.2488

G. Blumenthal, L. Zhang, H. Zhang, D. Kazandjian, S. Khozin et al., Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non???Small Cell Lung Cancer Trials, JAMA Oncology, vol.3, issue.8, p.171029, 2017.
DOI : 10.1001/jamaoncol.2017.1029